Benzoylecgonine and cross-reactive Cocaine Metabolites Immunoassay Reagent Kits

This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR 12.6 and FAR 13.5, Streamlined Procedures for Evaluation and Solicitation of Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. It is the contractor's responsibility to be familiar with the applicable FAR and DFARS clauses and provisions. The FAR and DFARS clauses may be accessed in full text at this address: http://farsite.hill.af.mil/

The NAICS code is 325413 with a business size standard of 500 employees. There are no set-aside restrictions for this requirement.

This Request for Proposal (RFP) is on behalf of the Department of Defense (DOD) Drug Demand Reduction Program (DDRP). This requirement is for immunoassay test reagent for the detection of Benzoylecgonine (BZE) and cross-reactive Cocaine Metabolites in urine.

The solicitation number is N62645-15-R-0002.

This solicitation will result in one firm fixed price requirements contract with a five year period of performance (a one-year base period and four one-year option periods). Period of Performance shall be from 01 October 2015 - 30 September 2020. The requirement will be fulfilled via an unrestricted, full and open competitive acquisition.

Proposal Submission
Proposals are due by 30 January 2015 by 02:00 PM Local Time. Proposals shall be submitted in accordance with the Instructions to Offeror of this request and a proposal submission confirmation emailed to Nicholas.Dankanich@med.navy.mil, (SUBJECT: N62645-15-R-0002 BZE Reagent Kits).